LUTHERVILLE, Md., April 17, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest results achieved by the real-time, stop-sale system in Kansas. Quarterly data released by the National Precursor Log Exchange (NPLEx) for the first part of 2012 shows electronic technology in the Sunflower State blocked the sale of more than 4,600 boxes of medicines containing pseudoephedrine (PSE) preventing more than 11,200 grams from potentially being diverted by meth criminals.
"Kansas' real-time, stop-sale technology is less than a year old. During a short period of time, the system is already showing undeniable results," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "NPLEx is a critically important resource in the battle against meth production. It allows retailers to block illegal sales of safe medications containing pseudoephedrine before they happen and provides police officers with criminal data in real time. By targeting criminals, NPLEx ensures that law-abiding citizens' access to effective cold and allergy medicines is not restricted. The latest quarterly numbers prove that NPLEx is working extremely well in Kansas."
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators